Industry insiders share what’s on their radar for next year.

We spoke with César de la Fuente to learn how he has developed AI models to discover and design novel antibiotics.

We spoke to Rebecca Goss to learn more about her precision molecular editing platform and its potential for drug development.

Yanyan Zhao shares an insight into the preclinical development of a PET imaging tracer for catching Alzheimer’s disease earlier.

In this interview, Namshik Han explains the role quantum algorithms can play in drug discovery research and what makes a successful startup.

Heather Pinkett tells us about her research investigating ABC transporters in pathogenic bacteria and what this could mean for tackling AMR.

Find out how developments in AlphaFold 3, alongside new predictive models, are changing approaches to drug discovery and design.

Current techniques and future directions

A myriad of advances are helping overcome current challenges.

The quality and diversity of the library are key to success

What are bacteriocins and how can we harness their therapeutic potential? Find out in this interview with the Glox Therapeutics Chair.

Here’s what newly appointed ELRIG Chair Del Trezise is looking forward to at Drug Discovery 2025. Plus, what we can expect from his term as Chair.